{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T03:25:13Z","timestamp":1792985113840,"version":"4.5.0"},"reference-count":126,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Microbiol Biotechnol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11274-025-04671-6","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T06:24:23Z","timestamp":1764224663000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Unravelling azole resistance in fungal pathogens: molecular mechanisms, diagnostic challenges, and therapeutic strategies"],"prefix":"10.1007","volume":"41","author":[{"given":"Chetana S.","family":"Eknure","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi P.","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogeshwar","family":"Bachhav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5097-3271","authenticated-orcid":false,"given":"Maushmi S.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"issue":"3","key":"4671_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2022.106518","volume":"59","author":"A Ahmadi","year":"2022","unstructured":"Ahmadi A, Mohammadnejadi E, Karami P, Razzaghi-Asl N (2022) Current status and structure activity relationship of privileged azoles as antifungal agents (2016\u20132020). Int J Antimicrob Agents 59(3):106518. https:\/\/doi.org\/10.1016\/j.ijantimicag.2022.106518","journal-title":"Int J Antimicrob Agents"},{"key":"4671_CR2","doi-asserted-by":"publisher","unstructured":"Ahmed MZ, Rao T, Saeed A, Mutahir Z, Hameed S, Inayat S, Shahzad H, Ullah N, Abaid-Ullah M, Ibrahim M, Munir MM, Javed S, Khan A, Khalid J, M., Ahmed S (2021) Antifungal drugs: mechanism of action and resistance. Biochem Drug Resist:143\u2013165. https:\/\/doi.org\/10.1007\/978-3-030-76320-6_5","DOI":"10.1007\/978-3-030-76320-6_5"},{"issue":"6","key":"4671_CR3","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1586\/14787210.2015.1032939","volume":"13","author":"D Allen","year":"2015","unstructured":"Allen D, Wilson D, Drew R, Perfect J (2015) Azole antifungals: 35 years of invasive fungal infection management. Expert Rev Anti-Infect Ther 13(6):787\u2013798. https:\/\/doi.org\/10.1586\/14787210.2015.1032939","journal-title":"Expert Rev Anti-Infect Ther"},{"issue":"2","key":"4671_CR4","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.peptides.2012.07.021","volume":"37","author":"AC Amaral","year":"2012","unstructured":"Amaral AC, Silva ON, Mundim NCCR, de Carvalho MJA, Migliolo L, Leite JRSA, Prates MV, Bocca AL, Franco OL, Felipe MSS (2012) Predicting antimicrobial peptides from eukaryotic genomes: in Silico strategies to develop antibiotics. Peptides 37(2):301\u2013308. https:\/\/doi.org\/10.1016\/j.peptides.2012.07.021","journal-title":"Peptides"},{"issue":"suppl3","key":"4671_CR5","doi-asserted-by":"publisher","first-page":"S445","DOI":"10.1093\/infdis\/jix131","volume":"216","author":"MC Arendrup","year":"2017","unstructured":"Arendrup MC, Patterson TF (2017) Multidrug-resistant Candida: epidemiology, molecular mechanisms, and treatment. J Infect Dis 216:S445\u2013S451. https:\/\/doi.org\/10.1093\/infdis\/jix131","journal-title":"J Infect Dis"},{"issue":"4","key":"4671_CR6","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/S12281-019-00354-6","volume":"13","author":"H Badali","year":"2019","unstructured":"Badali H, Wiederhold NP (2019) Antifungal resistance testing and implications for management. Curr Fungal Infect Rep 13(4):274\u2013283. https:\/\/doi.org\/10.1007\/S12281-019-00354-6","journal-title":"Curr Fungal Infect Rep"},{"issue":"5","key":"4671_CR7","doi-asserted-by":"publisher","first-page":"e01020","DOI":"10.1128\/mBio.01020-20","volume":"11","author":"B Ball","year":"2020","unstructured":"Ball B, Langille M, Geddes-McAlister J (2020) Fun(gi)omics: advanced and diverse technologies to explore emerging fungal pathogens and define mechanisms of antifungal resistance. Mbio 11(5):e01020. https:\/\/doi.org\/10.1128\/mBio.01020-20","journal-title":"mBio"},{"issue":"1","key":"4671_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-12-52","volume":"12","author":"R Becher","year":"2011","unstructured":"Becher R, Weihmann F, Deising HB, Wirsel SG (2011) Development of a novel multiplex DNA microarray for Fusarium graminearum and analysis of azole fungicide responses. BMC Genomics 12(1):52. https:\/\/doi.org\/10.1186\/1471-2164-12-52","journal-title":"BMC Genomics"},{"key":"4671_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-025-02084-7","author":"C B\u00e9dard","year":"2025","unstructured":"B\u00e9dard C, Pageau A, Fijarczyk A, Mendoza-Salido D, Alca\u00f1iz AJ, Despr\u00e9s PC, Durand R, Plante S, Alexander EMM, Rouleau FD, Jordan DF, Jay A, Gigu\u00e8re M, Bernier M, Sharma J, Maroc L, Gervais NC, Menon ACT, Gagnon-Arsenault I, Landry CR (2025) FungAMR: a comprehensive database for investigating fungal mutations associated with antimicrobial resistance. Nat Microbiol 1\u201315. https:\/\/doi.org\/10.1038\/s41564-025-02084-7","journal-title":"Nat Microbiol"},{"issue":"12","key":"4671_CR10","doi-asserted-by":"publisher","first-page":"e403","DOI":"10.1016\/S1473-3099(17)30443-7","volume":"17","author":"K Benedict","year":"2017","unstructured":"Benedict K, Richardson M, Vallabhaneni S, Jackson BR, Chiller T (2017) Emerging issues, challenges, and changing epidemiology of fungal disease outbreaks. Lancet Infect Dis 17(12):e403\u2013e411. https:\/\/doi.org\/10.1016\/S1473-3099(17)30443-7","journal-title":"Lancet Infect Dis"},{"key":"4671_CR11","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00069-19","author":"EL Berkow","year":"2020","unstructured":"Berkow EL, Lockhart SR, Ostrosky-Zeichner L (2020) Antifungal susceptibility testing: current approaches. Clin Microbiol Rev 33(3). https:\/\/doi.org\/10.1128\/cmr.00069-19","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"4671_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9060312","volume":"9","author":"S Bhattacharya","year":"2020","unstructured":"Bhattacharya S, Sae-Tia S, Fries BC (2020) Candidiasis and mechanisms of antifungal resistance. Antibiotics 9(6):312. https:\/\/doi.org\/10.3390\/antibiotics9060312","journal-title":"Antibiotics"},{"issue":"10","key":"4671_CR13","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01854-25","volume":"16","author":"L Bir\u0161tonas","year":"2025","unstructured":"Bir\u0161tonas L, Hortschansky P, Bauer I, Alcanzo EM, K\u00fchbacher A, Mertens B, Gsaller F (2025) The transcription factor RttA contributes to sterol regulation and azole resistance in Aspergillus fumigatus. Mbio e01854\u201325. https:\/\/doi.org\/10.1128\/mbio.01854-25","journal-title":"Mbio"},{"issue":"4","key":"4671_CR14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/jof3040057","volume":"3","author":"F Bongomin","year":"2017","unstructured":"Bongomin F, Gago S, Oladele RO, Denning DW (2017) Global and multi-national prevalence of fungal diseases-estimate precision. J Fungi 3(4):57. https:\/\/doi.org\/10.3390\/jof3040057","journal-title":"J Fungi"},{"issue":"1","key":"4671_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/jof9010080","volume":"9","author":"J Branco","year":"2023","unstructured":"Branco J, Miranda IM, Rodrigues AG (2023) Candida parapsilosis virulence and antifungal resistance mechanisms: a comprehensive review of key determinants. J Fungi 9(1):80. https:\/\/doi.org\/10.3390\/jof9010080","journal-title":"J Fungi"},{"issue":"7","key":"4671_CR16","doi-asserted-by":"publisher","first-page":"e1518","DOI":"10.1093\/cid\/ciaa1204","volume":"73","author":"SR Brand","year":"2021","unstructured":"Brand SR, Sobel JD, Nyirjesy P, Ghannoum MA, Schotzinger RJ, Degenhardt TP (2021) A randomized phase 2 study of VT-1161 for the treatment of acute vulvovaginal candidiasis. Clin Infect Dis 73(7):e1518\u2013e1524. https:\/\/doi.org\/10.1093\/cid\/ciaa1204","journal-title":"Clin Infect Dis"},{"issue":"15","key":"4671_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15151909","volume":"15","author":"L Brown","year":"2025","unstructured":"Brown L, Cruciani M, Morton CO, Alanio A, Barnes RA, Donnelly JP, Hagen F, Gorton R, Lackner M, Loeffler J, Millon L, Rautemaa-Richardson R, White PL (2025) The molecular diagnosis of invasive fungal diseases with a focus on PCR. Diagnostics 15(15):1909. https:\/\/doi.org\/10.3390\/diagnostics15151909","journal-title":"Diagnostics"},{"issue":"6","key":"4671_CR18","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1080\/14737159.2025.2477027","volume":"25","author":"R Chaudhary","year":"2025","unstructured":"Chaudhary R, Thakur Z (2025) From detection to action: new diagnostic insights into antifungal resistance. Expert Rev Mol Diagn 25(6):203\u2013208. https:\/\/doi.org\/10.1080\/14737159.2025.2477027","journal-title":"Expert Rev Mol Diagn"},{"issue":"13","key":"4671_CR19","doi-asserted-by":"publisher","first-page":"14054","DOI":"10.1021\/acs.jmedchem.5c01253","volume":"68","author":"Y Chen","year":"2025","unstructured":"Chen Y, Li Y, Nahar KS, Hasan MM, Marsh C, Clifford M, Aleku GA, Kelly SL, Lamb DC, Mpamhanga CD, Kounatidis I, Shah AJ, Hind CK, Sutton JM, Rahman KM (2025) New generation modified Azole antifungals against Multidrug-Resistant. J Med Chem 68(13):14054\u201314071. https:\/\/doi.org\/10.1021\/acs.jmedchem.5c01253","journal-title":"J Med Chem"},{"key":"4671_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112463","volume":"200","author":"Y-N Cheng","year":"2020","unstructured":"Cheng Y-N, Jiang Z-H, Sun L-S, Su Z-Y, Zhang M-M, Li H-L (2020) Synthesis of 1, 2, 4-triazole benzoyl arylamine derivatives and their high antifungal activities. Eur J Med Chem 200:112463. https:\/\/doi.org\/10.1016\/j.ejmech.2020.112463","journal-title":"Eur J Med Chem"},{"issue":"5","key":"4671_CR21","doi-asserted-by":"publisher","first-page":"697","DOI":"10.2217\/fmb.14.27","volume":"9","author":"A Chowdhary","year":"2014","unstructured":"Chowdhary A, Sharma C, Hagen F, Meis JF (2014) Exploring azole antifungal drug resistance in Aspergillus fumigatus with special reference to resistance mechanisms. Future Microbiol 9(5):697\u2013711. https:\/\/doi.org\/10.2217\/fmb.14.27","journal-title":"Future Microbiol"},{"issue":"1","key":"4671_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S40475-024-00336-W","volume":"12","author":"D Corr\u00eaa-Junior","year":"2025","unstructured":"Corr\u00eaa-Junior D, Frases S, Glauber GR (2025) Drug interactions of antifungal agents: clinical relevance and implications. Curr Trop Med Rep 12(1):1\u201313. https:\/\/doi.org\/10.1007\/S40475-024-00336-W","journal-title":"Curr Trop Med Rep"},{"key":"4671_CR23","unstructured":"Crous P, Stalpers J, Robert V (2004) MycoBank: an online initiative to launch mycology into the 21st century. Stud Mycol 50(2004):1, 50. https:\/\/edepot.wur.nl\/31039"},{"issue":"22","key":"4671_CR24","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.3390\/cells12222655","volume":"12","author":"KM Czajka","year":"2023","unstructured":"Czajka KM, Venkataraman K, Brabant-Kirwan D, Santi SA, Verschoor C, Appanna VD, Singh R, Saunders DP, Tharmalingam S (2023) Molecular mechanisms associated with antifungal resistance in pathogenic Candida species. Cells 2023 12(22):2655. https:\/\/doi.org\/10.3390\/cells12222655","journal-title":"Cells 2023"},{"key":"4671_CR25","doi-asserted-by":"publisher","unstructured":"Das M, Albert V, Sharma S, Singh G, Hallur VK, Pamidimukkala U, Singh KJ, Karuna T, Xess I, Savio J, Nath R, Gupta P, Shetty A, Das M, Albert V, Sharma S, Singh G, Hallur VK, Pamidimukkala U, \u2026, Shetty A (2025) Advancing fungal diagnostic and research stewardship in india: a prospective strategic 10-step plan for addressing a national public health challenge. Mycol - Med Perspect. https:\/\/doi.org\/10.5772\/intechopen.1009310","DOI":"10.5772\/intechopen.1009310"},{"issue":"7","key":"4671_CR26","doi-asserted-by":"publisher","first-page":"e428","DOI":"10.1016\/S1473-3099(23)00692-8","volume":"24","author":"DW Denning","year":"2024","unstructured":"Denning DW (2024) Global incidence and mortality of severe fungal disease. Lancet Infect Dis 24(7):e428\u2013e438. https:\/\/doi.org\/10.1016\/S1473-3099(23)00692-8","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"4671_CR27","first-page":"226","volume":"111","author":"DM Dixon","year":"1996","unstructured":"Dixon DM, McNeil MM, Cohen ML, Gellin BG, Montagne L, J. R (1996) Fungal infections: a growing threat. Public Health Rep 111(3):226. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC1381764\/","journal-title":"Public Health Rep"},{"issue":"6","key":"4671_CR28","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1097\/QCO.0000000000000103","volume":"27","author":"MJ Dolton","year":"2014","unstructured":"Dolton MJ, McLachlan AJ (2014) Optimizing Azole antifungal therapy in prophylaxis and treatment of fungal infections. Curr Opin Infect Dis 27(6):493\u2013500. https:\/\/doi.org\/10.1097\/QCO.0000000000000103","journal-title":"Curr Opin Infect Dis"},{"issue":"3","key":"4671_CR29","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1021\/acs.jmedchem.1c01807","volume":"65","author":"R Elias","year":"2022","unstructured":"Elias R, Basu P, Fridman M (2022) Fluconazole-COX inhibitor hybrids: a dual-acting class of antifungal azoles. J Med Chem 65(3):2361\u20132373. https:\/\/doi.org\/10.1021\/acs.jmedchem.1c01807","journal-title":"J Med Chem"},{"key":"4671_CR30","doi-asserted-by":"publisher","first-page":"518678","DOI":"10.3389\/fcimb.2020.00105","volume":"10","author":"M Fern\u00e1ndez de Ullivarri","year":"2020","unstructured":"Fern\u00e1ndez de Ullivarri M, Arbulu S, Garcia-Gutierrez E, Cotter PD (2020) Antifungal peptides as therapeutic agents. Front Cell Infect Microbiol 10:518678. https:\/\/doi.org\/10.3389\/fcimb.2020.00105","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"4671_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000268","volume":"5","author":"S Ferrari","year":"2009","unstructured":"Ferrari S, Ischer F, Calabrese D, Posteraro B, Sanguinetti M, Fadda G, Rohde B, Bauser C, Bader O, Sanglard D (2009) Gain of function mutations in CGPDR1 of Candida glabrata not only mediate antifungal resistance but also enhance virulence. PLoS Pathog 5(1):e1000268. https:\/\/doi.org\/10.1371\/journal.ppat.1000268","journal-title":"PLoS Pathog"},{"key":"4671_CR32","doi-asserted-by":"publisher","first-page":"409475","DOI":"10.3389\/fmicb.2018.02577","volume":"9","author":"W Florio","year":"2018","unstructured":"Florio W, Tavanti A, Ghelardi E, Lupetti A (2018) MALDI-TOF MS applications to the detection of antifungal resistance: state of the Art and future perspectives. Front Microbiol 9:409475. https:\/\/doi.org\/10.3389\/fmicb.2018.02577","journal-title":"Front Microbiol"},{"issue":"4","key":"4671_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/elife.00662","volume":"2015","author":"CB Ford","year":"2015","unstructured":"Ford CB, Funt JM, Abbey D, Issi L, Guiducci C, Martinez DA, Delorey T, Li BY, White T, Cuomo C, Rao RP, Berman J, Thompson DA, Regev A (2015) The evolution of drug resistance in clinical isolates of Candida albicans. ELife 2015(4):1\u201327. https:\/\/doi.org\/10.7554\/elife.00662","journal-title":"ELife"},{"issue":"6","key":"4671_CR34","doi-asserted-by":"publisher","first-page":"420","DOI":"10.37349\/eds.2023.00028","volume":"1","author":"LMT Frija","year":"2023","unstructured":"Frija LMT, Guerreiro BEC, Costa ICC, Isca VMS, Saraiva L, Neves BG, Magalh\u00e3es M, Cabral C, Cristiano MLS, Rijo P, Albericio F (2023) Hybrid azole-based conjugates as upcoming anticancer and antimicrobial agents. Open Explor 2019 1(6):420\u2013434. https:\/\/doi.org\/10.37349\/eds.2023.00028","journal-title":"Open Explor 2019"},{"issue":"2","key":"4671_CR35","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1128\/cmr.1.2.187","volume":"1","author":"RA Fromtling","year":"1988","unstructured":"Fromtling RA (1988) Overview of medically important antifungal azole derivatives. Clin Microbiol Rev 1(2):187\u2013217. https:\/\/doi.org\/10.1128\/cmr.1.2.187","journal-title":"Clin Microbiol Rev"},{"issue":"1\u20132","key":"4671_CR36","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/S10681-005-0626-3","volume":"145","author":"H Fufa","year":"2005","unstructured":"Fufa H, Baenziger PS, Beecher BS, Dweikat I, Graybosch RA, Eskridge KM (2005) Comparison of phenotypic and molecular marker-based classifications of hard red winter wheat cultivars. Euphytica 145(1\u20132):133\u2013146. https:\/\/doi.org\/10.1007\/S10681-005-0626-3","journal-title":"Euphytica"},{"issue":"3","key":"4671_CR37","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3390\/jof7030197","volume":"7","author":"G Garcia-Effron","year":"2021","unstructured":"Garcia-Effron G (2021) Molecular markers of antifungal resistance: potential uses in routine practice and future perspectives. J Fungi 7(3):197. https:\/\/doi.org\/10.3390\/jof7030197","journal-title":"J Fungi"},{"issue":"10","key":"4671_CR38","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1093\/jac\/dky242","volume":"73","author":"EP Garvey","year":"2018","unstructured":"Garvey EP, Sharp AD, Warn PA, Yates CM, Schotzinger RJ (2018) The novel fungal CYP51 inhibitor VT-1598 is efficacious alone and in combination with liposomal amphotericin B in a murine model of Cryptococcal meningitis. J Antimicrob Chemother 73(10):2815\u20132822. https:\/\/doi.org\/10.1093\/jac\/dky242","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"4671_CR39","doi-asserted-by":"publisher","first-page":"8480","DOI":"10.1039\/d4ra08220f","volume":"15","author":"M Harun-Ur-Rashid","year":"2025","unstructured":"Harun-Ur-Rashid M, Foyez T, Krishna SBN, Poda S, Imran A, Bin (2025) Recent advances of silver nanoparticle-based polymer nanocomposites for biomedical applications. RSC Adv 15(11):8480\u20138505. https:\/\/doi.org\/10.1039\/d4ra08220f","journal-title":"RSC Adv"},{"key":"4671_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-8-426","volume":"8","author":"C Hedeler","year":"2007","unstructured":"Hedeler C, Wong HM, Cornell MJ, Alam I, Soanes DM, Rattray M, Hubbard SJ, Talbot NJ, Oliver SG, Paton NW (2007) E-fungi: a data resource for comparative analysis of fungal genomes. BMC Genomics 8:426. https:\/\/doi.org\/10.1186\/1471-2164-8-426","journal-title":"BMC Genomics"},{"key":"4671_CR41","unstructured":"Herrick EJ, Patel P, Hashmi MF (2024) Antifungal ergosterol synthesis inhibitors. StatPearls. https:\/\/www.ncbi.nlm.nih.gov\/books\/nbk551581"},{"issue":"3","key":"4671_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/ph18030364","volume":"18","author":"HF Hetta","year":"2025","unstructured":"Hetta HF, Melhem T, Aljohani HM, Salama A, Ahmed R, Elfadil H, Alanazi FE, Ramadan YN, Battah B, Rottura M, Donadu MG (2025) Beyond conventional antifungals: combating resistance through novel therapeutic pathways. Pharmaceuticals 18(3):364. https:\/\/doi.org\/10.3390\/ph18030364","journal-title":"Pharmaceuticals"},{"key":"4671_CR43","doi-asserted-by":"publisher","unstructured":"Hoenigl M, Arastehfar A, Arendrup MC, Br\u00fcggemann R, Carvalho A, Chiller T, Chen S, Egger M, Feys S, Gangneux JP, Gold JAW, Groll AH, Heylen J, Jenks JD, Krause R, Lagrou K, Lamoth F, Prattes J, Sedik S, Thompson GR (2024) Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease. Clin Microbiol Rev 37(2). https:\/\/doi.org\/10.1128\/cmr.00074-23\/","DOI":"10.1128\/cmr.00074-23\/"},{"key":"4671_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.fgb.2019.103254","volume":"132","author":"MWJ Hokken","year":"2019","unstructured":"Hokken MWJ, Zwaan BJ, Melchers WJG, Verweij PE (2019) Facilitators of adaptation and antifungal resistance mechanisms in clinically relevant fungi. Fungal Genet Biol 132:103254. https:\/\/doi.org\/10.1016\/j.fgb.2019.103254","journal-title":"Fungal Genet Biol"},{"issue":"1","key":"4671_CR45","doi-asserted-by":"publisher","first-page":"e00127","DOI":"10.1128\/spectrum.00127-22","volume":"10","author":"C Hu","year":"2022","unstructured":"Hu C, Zhou M, Cao X, Xue W, Zhang Z, Li S, Sun X (2022) Coordinated regulation of membrane homeostasis and drug accumulation by novel kinase STK-17 in response to antifungal azole treatment. Microbiol Spectr 10(1):e00127\u201322. https:\/\/doi.org\/10.1128\/spectrum.00127-22","journal-title":"Microbiol Spectr"},{"issue":"2","key":"4671_CR46","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/S40588-024-00219-8","volume":"11","author":"ST Hui","year":"2024","unstructured":"Hui ST, Gifford H, Rhodes J (2024) Emerging antifungal resistance in fungal pathogens. Curr Clin Microbiol Rep 11(2):43\u201350. https:\/\/doi.org\/10.1007\/S40588-024-00219-8","journal-title":"Curr Clin Microbiol Rep"},{"issue":"1","key":"4671_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1743-7075-9-71","volume":"9","author":"MM Hussain","year":"2012","unstructured":"Hussain MM, Jin W, Jiang XC (2012) Mechanisms involved in cellular ceramide homeostasis. Nutr Metabolism 9(1):1\u20137. https:\/\/doi.org\/10.1186\/1743-7075-9-71","journal-title":"Nutr Metabolism"},{"issue":"1","key":"4671_CR48","doi-asserted-by":"publisher","first-page":"439","DOI":"10.5248\/114.439","volume":"114","author":"KD Hyde","year":"2011","unstructured":"Hyde KD, Abd-Elsalam K, Cai L (2011) Morphology: still essential in a molecular world. Mycotaxon 114(1):439\u2013451. https:\/\/doi.org\/10.5248\/114.439","journal-title":"Mycotaxon"},{"issue":"1","key":"4671_CR49","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/mmy\/myaa031","volume":"59","author":"AT Jamiu","year":"2021","unstructured":"Jamiu AT, Albertyn J, Sebolai OM, Pohl CH (2021) Update on Candida krusei, a potential multidrug-resistant pathogen. Med Mycol 59(1):14\u201330. https:\/\/doi.org\/10.1093\/mmy\/myaa031","journal-title":"Med Mycol"},{"issue":"3","key":"4671_CR50","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/S12281-019-00342-W","volume":"13","author":"JD Jenks","year":"2019","unstructured":"Jenks JD, Spiess B, Buchheidt D, Hoenigl M (2019) (New) methods for detection of Aspergillus fumigatus resistance in clinical samples. Curr Fungal Infect Rep 13(3):129\u2013136. https:\/\/doi.org\/10.1007\/S12281-019-00342-W","journal-title":"Curr Fungal Infect Rep"},{"issue":"9","key":"4671_CR51","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/aac.00833-17","volume":"61","author":"C Jim\u00e9nez-Ortigosa","year":"2017","unstructured":"Jim\u00e9nez-Ortigosa C, Perez WB, Angulo D, Borroto-Esoda K, Perlin DS (2017) acquisition of resistance to SCY-078 in involves mutations that both overlap and are distinct from those conferring echinocandin resistance. Antimicrob Agents Chemother 61(9):10\u20131128. https:\/\/doi.org\/10.1128\/aac.00833-17","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"4671_CR52","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1128\/AAC.48.3.693-715.2004","volume":"48","author":"MD Johnson","year":"2004","unstructured":"Johnson MD, MacDougall C, Ostrosky-Zeichner L, Perfect JR, Rex JH (2004) Combination antifungal therapy. Antimicrob Agents Chemother 48(3):693\u2013715. https:\/\/doi.org\/10.1128\/AAC.48.3.693-715.2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"Supplement3","key":"4671_CR53","doi-asserted-by":"publisher","first-page":"S175","DOI":"10.1093\/infdis\/jiaa394","volume":"222","author":"MD Johnson","year":"2020","unstructured":"Johnson MD, Lewis RE, Ashley D, Ostrosky-Zeichner ES, Zaoutis L, Thompson T, Kontoyiannis IIIGR, D. P (2020) Core recommendations for antifungal stewardship: a statement of the mycoses study group education and research consortium. J Infect Dis 222:S175\u2013S198. https:\/\/doi.org\/10.1093\/infdis\/jiaa394","journal-title":"J Infect Dis"},{"issue":"9","key":"4671_CR54","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.7164\/antibiotics.46.1414","volume":"46","author":"U Kastuhisa","year":"1993","unstructured":"Kastuhisa U, Tamio H, Hideyo Y, Fumiyo H, Yoshie Y, Ikunoshin K (1993) Biological properties of Aureobasidin a, a Cyclic depsipeptide antifungal antibiotic. J Antibiot 46(9):1414\u20131420. https:\/\/doi.org\/10.7164\/antibiotics.46.1414","journal-title":"J Antibiot"},{"issue":"6","key":"4671_CR55","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1080\/13693780802541518","volume":"47","author":"H Koga","year":"2009","unstructured":"Koga H, Nanjoh Y, Makimura K, Tsuboi R (2009) In vitro antifungal activities of luliconazole, a new topical imidazole. Med Mycol 47(6):640\u2013647. https:\/\/doi.org\/10.1080\/13693780802541518","journal-title":"Med Mycol"},{"key":"4671_CR56","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myac072.p011","author":"V Koparkar","year":"2022","unstructured":"Koparkar V, Soman R, Shetty A, Purandare B, Sunavala A, Doshi A (2022) P011 antifungal lock therapy. Med Mycol myac072P011. https:\/\/doi.org\/10.1093\/mmy\/myac072.p011","journal-title":"Med Mycol"},{"issue":"7","key":"4671_CR57","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1080\/17512433.2016.1185361","volume":"9","author":"LL Kovanda","year":"2016","unstructured":"Kovanda LL, Maher R, Hope WW (2016) Isavuconazonium sulfate: a new agent for the treatment of invasive aspergillosis and invasive mucormycosis. Expert Rev Clin Pharmacol 9(7):887\u2013897. https:\/\/doi.org\/10.1080\/17512433.2016.1185361","journal-title":"Expert Rev Clin Pharmacol"},{"key":"4671_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.610798","author":"M Krassowski","year":"2020","unstructured":"Krassowski M, Das V, Sahu SK, Misra BB (2020) State of the field in multi-omics research: from computational needs to data mining and sharing. Front Genet 11, 610798. https:\/\/doi.org\/10.3389\/fgene.2020.610798","journal-title":"Front Genet"},{"issue":"9","key":"4671_CR59","doi-asserted-by":"publisher","first-page":"DE01","DOI":"10.7860\/jcdr\/2018\/36218.11961","volume":"12","author":"L Krishnasamy","year":"2018","unstructured":"Krishnasamy L, Krishnakumar S, Kumaramanickavel G, Saikumar C (2018) Molecular mechanisms of antifungal drug resistance in Candida species. J Clin Diagn Res 12(9):DE01\u2013DE06. https:\/\/doi.org\/10.7860\/jcdr\/2018\/36218.11961","journal-title":"J Clin Diagn Res"},{"issue":"7","key":"4671_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2010-11-7-r77","volume":"11","author":"D Kuo","year":"2010","unstructured":"Kuo D, Tan K, Zinman G, Ravasi T, Bar-Joseph Z, Ideker T (2010) Evolutionary divergence in the fungal response to fluconazole revealed by soft clustering. Genome Biol 11(7):R77. https:\/\/doi.org\/10.1186\/gb-2010-11-7-r77","journal-title":"Genome Biol"},{"issue":"11","key":"4671_CR61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003022","volume":"8","author":"KJ Kwon-Chung","year":"2012","unstructured":"Kwon-Chung KJ, Chang YC (2012) Aneuploidy and drug resistance in pathogenic fungi. PLoS Pathog 8(11):e1003022. https:\/\/doi.org\/10.1371\/journal.ppat.1003022","journal-title":"PLoS Pathog"},{"issue":"1","key":"4671_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s44259-023-00007-2","volume":"1","author":"Y Lee","year":"2023","unstructured":"Lee Y, Robbins N, Cowen LE (2023) Molecular mechanisms governing antifungal drug resistance. NPJ Antimicrobials and Resistance 2023 1(1):1\u20139. https:\/\/doi.org\/10.1038\/s44259-023-00007-2","journal-title":"NPJ Antimicrobials and Resistance 2023"},{"key":"4671_CR63","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlaf106","author":"Y Li","year":"2025","unstructured":"Li Y, Hind C, Furner-Pardoe J, Sutton JM, Rahman KM (2025a) Understanding the mechanisms of resistance to Azole antifungals in Candida species. JAC-Antimicrobial Resistance 7(3), dlaf106. https:\/\/doi.org\/10.1093\/jacamr\/dlaf106","journal-title":"JAC-Antimicrobial Resistance"},{"key":"4671_CR64","doi-asserted-by":"publisher","first-page":"1610743","DOI":"10.3389\/fcimb.2025.1610743","volume":"15","author":"Y Li","year":"2025","unstructured":"Li Y, Qiao Y, Ma Y, Xue P, Ding C (2025b) AI in fungal drug development: opportunities, challenges, and outlook. Front Cell Infect Microbiol 15:1610743. https:\/\/doi.org\/10.3389\/fcimb.2025.1610743","journal-title":"Front Cell Infect Microbiol"},{"key":"4671_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.1065962","volume":"12","author":"J Lin","year":"2022","unstructured":"Lin J, Xiao X, Liang Y, Zhao H, Yu Y, Yuan P, Lu S, Ding X (2022) Repurposing non-antifungal drugs auranofin and pentamidine in combination as fungistatic antifungal agents against C. albicans. Front Cell Infect Microbiol 12:1065962. https:\/\/doi.org\/10.3389\/fcimb.2022.1065962","journal-title":"Front Cell Infect Microbiol"},{"issue":"9","key":"4671_CR66","doi-asserted-by":"publisher","first-page":"4465","DOI":"10.1128\/aac.02689-18","volume":"55","author":"SR Lockhart","year":"2011","unstructured":"Lockhart SR, Frade JP, Etienne KA, Pfaller MA, Diekema DJ, Balajee SA (2011) Azole resistance in Aspergillus fumigatus isolates from the ARTEMIS global surveillance study is primarily due to the TR\/L98H mutation in the CYP51A gene. Antimicrob Agents Chemother 55(9):4465\u20134468. https:\/\/doi.org\/10.1128\/aac.02689-18","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"4671_CR67","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/S1471-4914(02)02280-3","volume":"8","author":"A Lupetti","year":"2002","unstructured":"Lupetti A, Danesi R, Campa M, Tacca M, Del, Kelly S (2002) Molecular basis of resistance to Azole antifungals. Trends Mol Med 8(2):76\u201381. https:\/\/doi.org\/10.1016\/S1471-4914(02)02280-3","journal-title":"Trends Mol Med"},{"issue":"1","key":"4671_CR68","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/jpids\/piu083","volume":"5","author":"W McGhee","year":"2016","unstructured":"McGhee W, Michaels MG, Martin JM, Mazariegos GV, Green M (2016) Antifungal lock therapy with liposomal amphotericin B: a prospective trial. J Pediatr Infect Dis Soc 5(1):80\u201384. https:\/\/doi.org\/10.1093\/jpids\/piu083","journal-title":"J Pediatr Infect Dis Soc"},{"issue":"1","key":"4671_CR69","doi-asserted-by":"publisher","first-page":"R21","DOI":"10.1530\/jme-18-0055","volume":"62","author":"BB Misra","year":"2019","unstructured":"Misra BB, Langefeld C, Olivier M, Cox LA (2019) Integrated omics: tools, advances and future approaches. J Mol Endocrinol 62(1):R21\u2013R45. https:\/\/doi.org\/10.1530\/jme-18-0055","journal-title":"J Mol Endocrinol"},{"issue":"8","key":"4671_CR70","doi-asserted-by":"publisher","first-page":"795","DOI":"10.2174\/1573406412666160229150823","volume":"12","author":"M Mousavizadegan","year":"2016","unstructured":"Mousavizadegan M, Mohabatkar H (2016) An evaluation on different machine learning algorithms for classification and prediction of antifungal peptides. Med Chem 12(8):795\u2013800. https:\/\/doi.org\/10.2174\/1573406412666160229150823","journal-title":"Med Chem"},{"issue":"4","key":"4671_CR71","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4236\/pp.2024.154007","volume":"15","author":"S Mudenda","year":"2024","unstructured":"Mudenda S, Mudenda S (2024) Global burden of fungal infections and antifungal resistance from 1961 to 2024: findings and future implications. Pharmacol Amp; Pharm 15(4):81\u2013112. https:\/\/doi.org\/10.4236\/pp.2024.154007","journal-title":"Pharmacol Amp; Pharm"},{"key":"4671_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2022.1023542","volume":"10","author":"J Mussin","year":"2022","unstructured":"Mussin J, Giusiano G (2022) Biogenic silver nanoparticles as antifungal agents. Front Chem 1023542. https:\/\/doi.org\/10.3389\/fchem.2022.1023542","journal-title":"Front Chem"},{"issue":"10","key":"4671_CR73","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/aac.02689-18","volume":"63","author":"I Nakamura","year":"2019","unstructured":"Nakamura I, Ohsumi K, Takeda S, Katsumata K, Matsumoto S, Akamatsu S, Mitori H, Nakai T (2019) ASp2397 is a novel natural compound that exhibits rapid and potent fungicidal activity against species through a specific transporter. Antimicrob Agents Chemother 63(10):10\u20131128. https:\/\/doi.org\/10.1128\/aac.02689-18","journal-title":"Antimicrob Agents Chemother"},{"issue":"18","key":"4671_CR74","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1093\/bioinformatics\/bty321","volume":"34","author":"A Nash","year":"2018","unstructured":"Nash A, Sewell T, Farrer RA, Abdolrasouli A, Shelton JMG, Fisher MC, Rhodes J (2018) MARDy: mycology antifungal resistance database. Bioinformatics 34(18):3233\u20133234. https:\/\/doi.org\/10.1093\/bioinformatics\/bty321","journal-title":"Bioinformatics"},{"key":"4671_CR75","doi-asserted-by":"publisher","DOI":"10.1289\/ehp14722","author":"LK Neabore","year":"2024","unstructured":"Neabore LK (2024) Wake-up call: rapid increase in human fungal diseases under climate change. Environ Health Perspect 042001. https:\/\/doi.org\/10.1289\/ehp14722","journal-title":"Environ Health Perspect"},{"issue":"6","key":"4671_CR76","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1093\/jac\/dkx020","volume":"72","author":"H Nishikawa","year":"2017","unstructured":"Nishikawa H, Fukuda Y, Mitsuyama J, Tashiro M, Tanaka A, Takazono T, Saijo T, Yamamoto K, Nakamura S, Imamura Y, Miyazaki T, Kakeya H, Yamamoto Y, Yanagihara K, Mukae H, Kohno S, Izumikawa K (2017) In vitro and in vivo antifungal activities of T-2307, a novel arylamidine, against Cryptococcus gattii: an emerging fungal pathogen. J Antimicrob Chemother 72(6):1709\u20131713. https:\/\/doi.org\/10.1093\/jac\/dkx020","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"4671_CR77","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1146\/annurev-micro-091014-104330","volume":"69","author":"CJ Nobile","year":"2015","unstructured":"Nobile CJ, Johnson AD (2015) Candida albicans biofilms and human disease. Annu Rev Microbiol 69(1):71. https:\/\/doi.org\/10.1146\/annurev-micro-091014-104330","journal-title":"Annu Rev Microbiol"},{"issue":"1\u20132","key":"4671_CR78","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.cell.2011.10.048","volume":"148","author":"CJ Nobile","year":"2012","unstructured":"Nobile CJ, Fox EP, Nett JE, Sorrells TR, Mitrovich QM, Hernday AD, Tuch BB, Andes DR, Johnson AD (2012) A recently evolved transcriptional network controls biofilm development in Candida albicans. Cell 148(1\u20132):126\u2013138. https:\/\/doi.org\/10.1016\/j.cell.2011.10.048","journal-title":"Cell"},{"issue":"45","key":"4671_CR79","doi-asserted-by":"publisher","first-page":"12809","DOI":"10.1073\/pnas.1608304113","volume":"113","author":"JD Oliver","year":"2016","unstructured":"Oliver JD, Sibley GEM, Beckmann N, Dobb KS, Slater MJ, McEntee L, Du Pr\u00e9 S, Livermore J, Bromley MJ, Wiederhold NP, Hope WW, Kennedy AJ, Law D, Birch M (2016) F901318 represents a novel class of antifungal drug that inhibits dihydroorotate dehydrogenase. Proc Natl Acad Sci USA 113(45):12809\u201312814. https:\/\/doi.org\/10.1073\/pnas.1608304113","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"4671_CR80","doi-asserted-by":"publisher","first-page":"6872","DOI":"10.1128\/aac.00701-16","volume":"60","author":"V Ong","year":"2016","unstructured":"Ong V, Hough G, Schlosser M, Bartizal K, Balkovec JM, James KD, Krishnan BR (2016) Preclinical evaluation of the stability, safety, and efficacy of CD101, a novel echinocandin. Antimicrob Agents Chemother 60(11):6872\u20136879. https:\/\/doi.org\/10.1128\/aac.00701-16","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"4671_CR81","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1074\/mcp.m114.045344","volume":"15","author":"P Pais","year":"2016","unstructured":"Pais P, Costa C, Pires C, Shimizu K, Chibana H, Teixeira MC (2016) Membrane proteome-wide response to the antifungal drug clotrimazole in Candida glabrata: role of the transcription factor CgPdr1 and the drug:H\u2009+\u2009antiporters CgTpo1_1 and CgTpo1_2. Mol Cell Proteomics: MCP 15(1):57\u201372. https:\/\/doi.org\/10.1074\/mcp.m114.045344","journal-title":"Mol Cell Proteomics: MCP"},{"key":"4671_CR82","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10061208","volume":"2022","author":"BY Parslow","year":"2022","unstructured":"Parslow BY, Thornton CR (2022) Continuing shifts in epidemiology and antifungal susceptibility highlight the need for improved disease management of invasive candidiasis. Microorganisms 2022:1208. https:\/\/doi.org\/10.3390\/microorganisms10061208","journal-title":"Microorganisms"},{"issue":"1","key":"4671_CR83","doi-asserted-by":"publisher","first-page":"e0245160","DOI":"10.1371\/journal.pone.0245160","volume":"16","author":"S Paul","year":"2021","unstructured":"Paul S, Dadwal R, Singh S, Shaw D, Chakrabarti A, Rudramurthy SM, Ghosh AK (2021) Rapid detection of ERG11 polymorphism associated with Azole resistance in Candida tropicalis. PLoS ONE 16(1):e0245160. https:\/\/doi.org\/10.1371\/journal.pone.0245160","journal-title":"PLoS ONE"},{"issue":"suppl3","key":"4671_CR84","doi-asserted-by":"publisher","first-page":"S458","DOI":"10.1093\/infdis\/jix121","volume":"216","author":"DS Perlin","year":"2017","unstructured":"Perlin DS, Wiederhold NP (2017) Culture-independent molecular methods for detection of antifungal resistance mechanisms and fungal identification. J Infect Dis 21458\u2013465. https:\/\/doi.org\/10.1093\/infdis\/jix121","journal-title":"J Infect Dis"},{"issue":"12","key":"4671_CR85","doi-asserted-by":"publisher","first-page":"e383","DOI":"10.1016\/S1473-3099(17)30316-X","volume":"17","author":"DS Perlin","year":"2017","unstructured":"Perlin DS, Rautemaa-Richardson R, Alastruey-Izquierdo A (2017) The global problem of antifungal resistance: prevalence, mechanisms, and management. Lancet Infect Dis 17(12):e383\u2013e392. https:\/\/doi.org\/10.1016\/S1473-3099(17)30316-X","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"4671_CR86","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1128\/aac.01599-12","volume":"57","author":"BM Peters","year":"2013","unstructured":"Peters BM, Ward RM, Rane HS, Lee SA, Noverr MC (2013) Efficacy of ethanol against Candida albicans and Staphylococcus aureus polymicrobial biofilms. Antimicrob Agents Chemother 57(1):74\u201382. https:\/\/doi.org\/10.1128\/aac.01599-12","journal-title":"Antimicrob Agents Chemother"},{"key":"4671_CR87","doi-asserted-by":"publisher","DOI":"10.3390\/jof10040293","author":"R Petraitiene","year":"2024","unstructured":"Petraitiene R, Petraitis V, Zaw MH, Hussain K, Ricart Arbona RJ, Roilides E, Walsh TJ (2024) Combination of systemic and lock-therapies with micafungin eradicate catheter-based biofilms and infections caused by Candida albicans and Candida parapsilosis in neutropenic rabbit models. J Fungi 10(4):293. https:\/\/doi.org\/10.3390\/jof10040293","journal-title":"J Fungi"},{"issue":"11","key":"4671_CR88","doi-asserted-by":"publisher","first-page":"5155","DOI":"10.1128\/aac.00570-11","volume":"55","author":"MA Pfaller","year":"2011","unstructured":"Pfaller MA, Duncanson F, Messer SA, Moet GJ, Jones RN, Castanheira M (2011) In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Aspergillus spp. determined by CLSI and EUCAST broth microdilution methods. Antimicrob Agents Chemother 55(11):5155\u20135158. https:\/\/doi.org\/10.1128\/aac.00570-11","journal-title":"Antimicrob Agents Chemother"},{"key":"4671_CR89","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/978-3-319-25304-6_14","volume":"892","author":"R Prasad","year":"2016","unstructured":"Prasad R, Shah AH, Rawal MK (2016) Antifungals: mechanism of action and drug resistance. Adv Exp Med Biol 892:327\u2013349. https:\/\/doi.org\/10.1007\/978-3-319-25304-6_14","journal-title":"Adv Exp Med Biol"},{"key":"4671_CR90","doi-asserted-by":"publisher","DOI":"10.62541\/jaspi069","author":"J Rajbongshi","year":"2025","unstructured":"Rajbongshi J, Durairaj E (2025) Antifungal stewardship-principles, current practices, limitations, and potential solutions: a narrative review. J Antimicrob Stewardship Pract Infec Dis 26\u201336. https:\/\/doi.org\/10.62541\/jaspi069","journal-title":"Journal of Antimicrobial Stewardship Practices and Infectious diseases"},{"key":"4671_CR91","doi-asserted-by":"publisher","unstructured":"Ramos Irizarry P, Smith DFQ, Gusa A (2025) Climate change impact on environmental fungi: human health and fungal disease. 1\u201335. https:\/\/doi.org\/10.1007\/82_2025_305","DOI":"10.1007\/82_2025_305"},{"key":"4671_CR92","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa016","author":"AM Rauseo","year":"2020","unstructured":"Rauseo AM, Coler-Reilly A, Larson L, Spec A (2020) Hope on the horizon: novel fungal treatments in development. Open Forum Infect Dis 7(2), p. ofaa016. https:\/\/doi.org\/10.1093\/ofid\/ofaa016","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"4671_CR93","doi-asserted-by":"publisher","first-page":"5","DOI":"10.25259\/ijdvl_91_2022","volume":"89","author":"A Ray","year":"2023","unstructured":"Ray A, Das A, Panda S (2023) Antifungal stewardship: what we need to know. Indian J Dermatol Venereol Leprol 89(1):5\u201311. https:\/\/doi.org\/10.25259\/ijdvl_91_2022","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"4671_CR94","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.mib.2018.02.005","volume":"45","author":"NM Revie","year":"2018","unstructured":"Revie NM, Iyer KR, Robbins N, Cowen LE (2018) Antifungal drug resistance: evolution, mechanisms and impact. Curr Opin Microbiol 45:70\u201376. https:\/\/doi.org\/10.1016\/j.mib.2018.02.005","journal-title":"Curr Opin Microbiol"},{"key":"4671_CR95","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1146\/annurev-micro-030117-020345","volume":"71","author":"N Robbins","year":"2017","unstructured":"Robbins N, Caplan T, Cowen LE (2017) Molecular evolution of antifungal drug resistance. Annu Rev Microbiol 71:753\u2013775. https:\/\/doi.org\/10.1146\/annurev-micro-030117-020345","journal-title":"Annu Rev Microbiol"},{"issue":"2","key":"4671_CR96","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007964","volume":"14","author":"ML Rodrigues","year":"2020","unstructured":"Rodrigues ML, Nosanchuk JD (2020) Fungal diseases as neglected pathogens: a wake-up call to public health officials. PLoS Negl Trop Dis 14(2):e0007964. https:\/\/doi.org\/10.1371\/journal.pntd.0007964","journal-title":"PLoS Negl Trop Dis"},{"key":"4671_CR97","doi-asserted-by":"publisher","unstructured":"Ruiz-Baca E, Arredondo-S\u00e1nchez RI, Corral-P\u00e9rez K, L\u00f3pez-Rodr\u00edguez A, Meneses-Morales I, Ayala-Garc\u00eda VM, Mart\u00ednez-Rocha AL, Ruiz-Baca E, Arredondo-S\u00e1nchez RI, Corral-P\u00e9rez K, L\u00f3pez-Rodr\u00edguez A, Meneses-Morales I, Ayala-Garc\u00eda VM, Mart\u00ednez-Rocha AL (2021) Molecular mechanisms of resistance to antifungals in Candida albicans. https:\/\/doi.org\/10.5772\/intechopen.96346","DOI":"10.5772\/intechopen.96346"},{"issue":"1","key":"4671_CR98","doi-asserted-by":"publisher","first-page":"50","DOI":"10.25259\/jsstd_61_2021","volume":"5","author":"NV Sahadevan","year":"2023","unstructured":"Sahadevan NV (2023) Drug interactions of Azole antifungals. J Skin Sexually Transmitted Dis 5(1):50\u201354. https:\/\/doi.org\/10.25259\/jsstd_61_2021","journal-title":"J Skin Sexually Transmitted Dis"},{"issue":"7","key":"4671_CR99","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1111\/J.1567-1364.2009.00578.X","volume":"9","author":"D Sanglard","year":"2009","unstructured":"Sanglard D, Coste A, Ferrari S (2009) Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation. FEMS Yeast Res 9(7):1029\u20131050. https:\/\/doi.org\/10.1111\/J.1567-1364.2009.00578.X","journal-title":"FEMS Yeast Res"},{"issue":"9","key":"4671_CR100","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008819","volume":"16","author":"W Scott Moye-Rowley","year":"2020","unstructured":"Scott Moye-Rowley W (2020) Linkage between genes involved in azole resistance and ergosterol biosynthesis. PLoS Pathog 16(9):e1008819. https:\/\/doi.org\/10.1371\/journal.ppat.1008819","journal-title":"PLoS Pathog"},{"key":"4671_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2020.104240","volume":"104","author":"M Shafiei","year":"2020","unstructured":"Shafiei M, Peyton L, Hashemzadeh M, Foroumadi A (2020) History of the development of antifungal azoles: a review on structures, SAR, and mechanism of action. Bioorg Chem 104:104240. https:\/\/doi.org\/10.1016\/j.bioorg.2020.104240","journal-title":"Bioorg Chem"},{"issue":"1","key":"4671_CR102","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s12281-023-00455-3","volume":"17","author":"M Sharma","year":"2023","unstructured":"Sharma M, Chakrabarti A (2023) Candidiasis and other emerging yeasts. Curr Fungal Infect Rep 17(1):15\u201324. https:\/\/doi.org\/10.1007\/s12281-023-00455-3","journal-title":"Curr Fungal Infect Rep"},{"key":"4671_CR103","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01128-21","author":"S Siscar-Lewin","year":"2021","unstructured":"Siscar-Lewin S, Gabald\u00f3n T, Aldejohann AM, Kurzai O, Hube B, Brunke S (2021) Transient mitochondria dysfunction confers fungal cross-resistance against phagocytic killing and fluconazole. MBio 12(3):10\u20131128. https:\/\/doi.org\/10.1128\/mbio.01128-21","journal-title":"MBio"},{"issue":"14","key":"4671_CR104","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1080\/14656566.2021.1935868","volume":"22","author":"AG Stewart","year":"2021","unstructured":"Stewart AG, Paterson DL (2021) How urgent is the need for new antifungals? Expert Opin Pharmacother 22(14):1857\u20131870. https:\/\/doi.org\/10.1080\/14656566.2021.1935868","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"4671_CR105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-017-2852-x","volume":"10","author":"SH Subramanya","year":"2017","unstructured":"Subramanya SH, Baral BP, Sharan NK, Nayak N, Metok Y, Sathian B, Bairy I, Gokhale S (2017) Antifungal susceptibility and phenotypic virulence markers of Candida species isolated from Nepal. BMC Res Notes 10(1):1\u20137. https:\/\/doi.org\/10.1186\/s13104-017-2852-x","journal-title":"BMC Res Notes"},{"key":"4671_CR106","doi-asserted-by":"publisher","unstructured":"Sun YV, Hu Y-J (2016) Chapter three\u2014Integrative analysis of multi-omics data for discovery and functional studies of complex human diseases. In: Friedmann T, Dunlap JC, Goodwin SF (eds) Advances in genetics, vol 93. Academic Press, pp 147\u2013190. https:\/\/doi.org\/10.1016\/bs.adgen.2015.11.004","DOI":"10.1016\/bs.adgen.2015.11.004"},{"issue":"11","key":"4671_CR107","doi-asserted-by":"publisher","DOI":"10.3390\/ph15111427","volume":"15","author":"MM Teixeira","year":"2022","unstructured":"Teixeira MM, Carvalho DT, Sousa E, Pinto E (2022) New antifungal agents with azole moieties. Pharmaceuticals 15(11):1427. https:\/\/doi.org\/10.3390\/ph15111427","journal-title":"Pharmaceuticals"},{"issue":"4","key":"4671_CR108","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1128\/aac.05720-11","volume":"56","author":"LA Vale-Silva","year":"2012","unstructured":"Vale-Silva LA, Coste AT, Ischer F, Parker JE, Kelly SL, Pinto E, Sanglard D (2012) Azole resistance by loss of function of the sterol \u2206 5,6- desaturase gene (ERG3) in Candida albicans does not necessarily decrease virulence. Antimicrob Agents Chemother 56(4):1960\u20131968. https:\/\/doi.org\/10.1128\/aac.05720-11","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"4671_CR109","doi-asserted-by":"publisher","DOI":"10.3390\/JOF6010012","volume":"6","author":"MH Van der Torre","year":"2020","unstructured":"Van der Torre MH, Novak-frazer L, Rautemaa-richardson R (2020) Detecting azole-antifungal resistance in Aspergillus fumigatus by pyrosequencing. J Fungi 6(1):12. https:\/\/doi.org\/10.3390\/JOF6010012","journal-title":"J Fungi"},{"issue":"2","key":"4671_CR110","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1021\/acssynbio.4c00816","volume":"14","author":"JE Van Dongen","year":"2025","unstructured":"Van Dongen JE, Segerink LI (2025) Building the future of clinical diagnostics: an analysis of potential benefits and current barriers in CRISPR\/Cas diagnostics. ACS Synth Biol 14(2):323\u2013331. https:\/\/doi.org\/10.1021\/acssynbio.4c00816","journal-title":"ACS Synth Biol"},{"issue":"8","key":"4671_CR111","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1038\/S41564-025-02055","volume":"10","author":"N Van Rhijn","year":"2025","unstructured":"Van Rhijn N, Rhodes J (2025) Evolution of antifungal resistance in the environment. Nat Microbiol 10(8):1804\u20131815. https:\/\/doi.org\/10.1038\/S41564-025-02055","journal-title":"Nat Microbiol"},{"key":"4671_CR112","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00764-24","author":"F Wan","year":"2025","unstructured":"Wan F, Zhang M, Guo J, Lin H, Zhou X, Wang L, Wu W (2025) A MALDI-TOF MS-based multiple detection panel of drug resistance-associated multiple single-nucleotide polymorphisms in Candida tropicalis. Microbiol Spectr 13(1):e00764\u201324. https:\/\/doi.org\/10.1128\/spectrum.00764-24","journal-title":"Microbiol Spectr"},{"key":"4671_CR113","doi-asserted-by":"publisher","unstructured":"Wang Z, Nilsson RH, James TY, Dai Y, Townsend JP (2016) Future perspectives and challenges of fungal systematics in the age of big data. In: Li D-W (ed) Biology of microfungi. Springer International Publishing, pp 25\u201346. https:\/\/doi.org\/10.1007\/978-3-319-29137-6_3","DOI":"10.1007\/978-3-319-29137-6_3"},{"issue":"1","key":"4671_CR114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13756-021-00890-2","volume":"10","author":"D Wang","year":"2021","unstructured":"Wang D, An N, Yang Y, Yang X, Fan Y, Feng J (2021) Candida tropicalis distribution and drug resistance is correlated with ERG11 and UPC2 expression. Antimicrob Resist Infect Control 10(1):1\u20139. https:\/\/doi.org\/10.1186\/s13756-021-00890-2","journal-title":"Antimicrob Resist Infect Control"},{"key":"4671_CR115","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.02173","volume":"7","author":"SG Whaley","year":"2017","unstructured":"Whaley SG, Berkow EL, Rybak JM, Nishimoto AT, Barker KS, Rogers PD (2017) Azole antifungal resistance in Candida albicans and emerging non-albicans Candida species. Front Microbiol 7:2173. https:\/\/doi.org\/10.3389\/fmicb.2016.02173","journal-title":"Front Microbiol"},{"key":"4671_CR116","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2147\/idr.s124918","volume":"10","author":"NP Wiederhold","year":"2017","unstructured":"Wiederhold NP (2017) Antifungal resistance: current trends and future strategies to combat. Infect Drug Resist 10:249. https:\/\/doi.org\/10.2147\/idr.s124918","journal-title":"Infect Drug Resist"},{"issue":"6","key":"4671_CR117","doi-asserted-by":"publisher","first-page":"688","DOI":"10.3390\/jof9060688","volume":"9","author":"NN Wijayawardene","year":"2023","unstructured":"Wijayawardene NN, Boonyuen N, Ranaweera CB, de Zoysa HK, Padmathilake RE, Nifla F, Dai D-Q, Liu Y, Suwannarach N, Kumla J (2023) OMICS and other advanced technologies in mycological applications. J Fungi 9(6):688. https:\/\/doi.org\/10.3390\/jof9060688","journal-title":"J Fungi"},{"issue":"2","key":"4671_CR118","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0021-9258(18)72045-0","volume":"152","author":"DW Woolley","year":"1944","unstructured":"Woolley DW (1944) Some biological effects produced by benzimidazole and their reversal by purines. J Biol Chem 152(2):225\u2013232. https:\/\/doi.org\/10.1016\/S0021-9258(18)72045-0","journal-title":"J Biol Chem"},{"key":"4671_CR119","unstructured":"World Health Organization (2022) WHO fungal priority pathogens list to guide research, development and public health action. World Health Organization. https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/69af4379-4f27-4ac4-8973-74d7b52af7bd\/"},{"issue":"3","key":"4671_CR120","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1021\/cr60151a002","volume":"48","author":"JB Wright","year":"1951","unstructured":"Wright JB (1951) The chemistry of the benzimidazoles. Chem Rev 48(3):397\u2013541. https:\/\/doi.org\/10.1021\/cr60151a002","journal-title":"Chem Rev"},{"key":"4671_CR121","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.793419","volume":"11","author":"Y Wu","year":"2022","unstructured":"Wu Y, Hu S, Wu C, Gu F, Yang Y (2022a) Probiotics: potential novel therapeutics against fungal infections. Front Cell Infect Microbiol 11:793419. https:\/\/doi.org\/10.3389\/fcimb.2021.793419","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"4671_CR122","doi-asserted-by":"publisher","DOI":"10.1038\/S41421-022-00495-Y","volume":"8","author":"Y Wu","year":"2022","unstructured":"Wu Y, Zhang M, Yang Y, Ding X, Yang P, Huang K, Hu X, Zhang M, Liu X, Yu H (2022b) Structures and mechanism of chitin synthase and its inhibition by antifungal drug Nikkomycin Z. Cell Discov 8(1):129. https:\/\/doi.org\/10.1038\/S41421-022-00495-Y","journal-title":"Cell Discov"},{"issue":"D1","key":"4671_CR123","doi-asserted-by":"publisher","first-page":"D996","DOI":"10.1093\/nar\/gkab1007","volume":"50","author":"AD Yates","year":"2022","unstructured":"Yates AD, Allen J, Amode RM, Azov AG, Barba M, Becerra A, Bhai J, Campbell LI, Martinez C, Chakiachvili M, Chougule M, Christensen K, Contreras-Moreira M, Cuzick B, Da Rin Fioretto A, Davis L, De Silva P, Diamantakis NH, Dyer S, Flicek S, P (2022) Ensembl genomes 2022: an expanding genome resource for non-vertebrates. Nucleic Acids Res 50(D1):D996\u2013D1003. https:\/\/doi.org\/10.1093\/nar\/gkab1007","journal-title":"Nucleic Acids Res"},{"key":"4671_CR124","doi-asserted-by":"publisher","unstructured":"Zhang Y, Xu J (2018) Molecular mechanisms of fungal adaptive evolution. Grand challenges in biology and biotechnology. pp 409\u2013435. https:\/\/doi.org\/10.1007\/978-3-319-69078-0_15","DOI":"10.1007\/978-3-319-69078-0_15"},{"key":"4671_CR125","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.2147\/dddt.s185833","volume":"12","author":"YH Zheng","year":"2018","unstructured":"Zheng YH, Ma YY, Ding Y, Chen XQ, Gao GX (2018) An insight into new strategies to combat antifungal drug resistance. Drug Des Devel Ther 12:3807\u20133816. https:\/\/doi.org\/10.2147\/dddt.s185833","journal-title":"Drug Des Devel Ther"},{"key":"4671_CR126","doi-asserted-by":"publisher","unstructured":"Zia Q, Fatima N, Alam M, Bisht D, Yadav P, Ahmad I, Aqil F, Owais M (2010) Immunomodulators: potential in treatment of systemic fungal infections.\u00a0Combating fungal infections: problems and remedy. pp 397\u2013421. https:\/\/doi.org\/10.1007\/978-3-642-12173-9_17","DOI":"10.1007\/978-3-642-12173-9_17"}],"container-title":["World Journal of Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11274-025-04671-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11274-025-04671-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11274-025-04671-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T04:29:59Z","timestamp":1767673799000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11274-025-04671-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":126,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["4671"],"URL":"https:\/\/doi.org\/10.1007\/s11274-025-04671-6","relation":{},"ISSN":["0959-3993","1573-0972"],"issn-type":[{"value":"0959-3993","type":"print"},{"value":"1573-0972","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"16 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"476"}}